EVA1A and hepatocellular carcinoma: We also reveal that miR-103a-3p promotes HCC cell growth and mobility by targeting EVA1A and further downregulating TP53; in turn, downregulation of miR-103a-3p induces HCC cell apoptosis by upregulating the EVA1A/TP53 pathway (Fig. 9).